Literature DB >> 15271991

Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels.

Guillermo Vazquez1, Barbara J Wedel, Brian T Kawasaki, Gary St John Bird, James W Putney.   

Abstract

Members of the canonical transient receptor potential (TRPC) subfamily of cation channels are candidates for capacitative and non-capacitative Ca2+ entry channels. When ectopically expressed in cell lines, TRPC3 can be activated by phospholipase C-mediated generation of diacylglycerol or by addition of synthetic diacylglycerols, independently of Ca2+ store depletion. Apart from this mode of regulation, little is known about other receptor-dependent signaling events that modulate TRPC3 activity. In the present study the role of tyrosine kinases in receptor- and diacylglycerol-dependent activation of TRPC3 was investigated. In HEK293 cells stably expressing TRPC3, pharmacological inhibition of tyrosine kinases, and specifically of Src kinases, abolished activation of TRPC3 by muscarinic receptor stimulation and by diacylglycerol. Channel regulation was lost following expression of a dominant-negative mutant of Src, or when TRPC3 was expressed in an Src-deficient cell line. In both instances, wild-type Src restored TRPC3 regulation. We conclude that Src plays an obligatory role in the mechanism for receptor and diacylglycerol activation of TRPC3. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271991     DOI: 10.1074/jbc.M405280200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Phospholipase C signaling and calcium influx.

Authors:  James W Putney; Takuro Tomita
Journal:  Adv Biol Regul       Date:  2012-01

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells.

Authors:  Ryo Suzuki; Xibao Liu; Ana Olivera; Lizath Aguiniga; Yumi Yamashita; Ulrich Blank; Indu Ambudkar; Juan Rivera
Journal:  J Leukoc Biol       Date:  2010-06-22       Impact factor: 4.962

4.  Increased size and cellularity of advanced atherosclerotic lesions in mice with endothelial overexpression of the human TRPC3 channel.

Authors:  Kathryn B Smedlund; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

5.  Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.

Authors:  Motohiro Nishida; Kenta Watanabe; Yoji Sato; Michio Nakaya; Naoyuki Kitajima; Tomomi Ide; Ryuji Inoue; Hitoshi Kurose
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

Review 6.  Physiological mechanisms of TRPC activation.

Authors:  James W Putney
Journal:  Pflugers Arch       Date:  2005-08-18       Impact factor: 3.657

Review 7.  TRPC3: a versatile transducer molecule that serves integration and diversification of cellular signals.

Authors:  Klaus Groschner; Christian Rosker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 8.  Functional role of TRPC channels in the regulation of endothelial permeability.

Authors:  Gias U Ahmmed; Asrar B Malik
Journal:  Pflugers Arch       Date:  2005-06-30       Impact factor: 3.657

Review 9.  The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance.

Authors:  Alexander Dietrich; Hermann Kalwa; Benjamin R Rost; Thomas Gudermann
Journal:  Pflugers Arch       Date:  2005-06-22       Impact factor: 3.657

Review 10.  Protein-protein interaction and functionTRPC channels.

Authors:  Kirill Kiselyov; Joo Young Kim; Weizhong Zeng; Shmuel Muallem
Journal:  Pflugers Arch       Date:  2005-07-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.